Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

Cancelled under Section 30(1)(c) of the Act

Clear all

24849 result(s) found, displaying 5976 to 6000

ANGEVOUR darbepoetin alfa (rch) 150 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 200 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 40 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 50 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 500 microgram/1.0mL solution for injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 60 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 80 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
Juice Plus+ Berry Blend Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by The Juice Plus Company Australia Pty Ltd
NUVARING etonogestrel 11.7mg and ethinylestradiol 2.7mg vaginal drug delivery system Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 20/5 olmesartan medoxomil 20 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 40/10 olmesartan medoxomil 40 mg and amlodipine (as besilate) 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 40/5 olmesartan medoxomil 40 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
EVEROLIMUS SANDOZ everolimus 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 September 2023

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
EVEROLIMUS SANDOZ everolimus 2.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 September 2023

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
EVEROLIMUS SANDOZ everolimus 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 September 2023

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
Trueferrin Bone + Muscle Support Cancelled under Section 30(1)(c) of the Act

5 September 2023

Cancellation by sponsor

Requested by Beston Pure Dairies Pty Ltd
Trueferrin Growth + Immune Support Cancelled under Section 30(1)(c) of the Act

5 September 2023

Cancellation by sponsor

Requested by Beston Pure Dairies Pty Ltd
Trueferrin Immune+ Cancelled under Section 30(1)(c) of the Act

5 September 2023

Cancellation by sponsor

Requested by Beston Pure Dairies Pty Ltd
Goody Goody Sun Drops Cancelled under Section 30(1)(c) of the Act

31 August 2023

Cancellation by sponsor

Requested by York St Brands Pty Ltd
PREGNYL gonadotrophin - chorionic human 1500IU powder for injection vial with diluent vial Cancelled under Section 30(1)(c) of the Act

31 August 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
PREGNYL gonadotrophin - chorionic human 5000IU powder for injection vial with diluent vial Cancelled under Section 30(1)(c) of the Act

31 August 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
SINEMET CR levodopa/carbidopa 200 mg/50 mg modified release tablet bottle Cancelled under Section 30(1)(c) of the Act

31 August 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

ANGEVOUR darbepoetin alfa (rch) 150 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 200 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 40 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 50 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 500 microgram/1.0mL solution for injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 60 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 80 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

Juice Plus+ Berry Blend Cancelled under Section 30(1)(c) of the Act

NUVARING etonogestrel 11.7mg and ethinylestradiol 2.7mg vaginal drug delivery system Cancelled under Section 30(1)(c) of the Act

OLMESARTAN/ AMLODIPINE - DSK 20/5 olmesartan medoxomil 20 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

OLMESARTAN/ AMLODIPINE - DSK 40/10 olmesartan medoxomil 40 mg and amlodipine (as besilate) 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

OLMESARTAN/ AMLODIPINE - DSK 40/5 olmesartan medoxomil 40 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

EVEROLIMUS SANDOZ everolimus 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

EVEROLIMUS SANDOZ everolimus 2.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

EVEROLIMUS SANDOZ everolimus 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

Trueferrin Bone + Muscle Support Cancelled under Section 30(1)(c) of the Act

Trueferrin Growth + Immune Support Cancelled under Section 30(1)(c) of the Act

Trueferrin Immune+ Cancelled under Section 30(1)(c) of the Act

Goody Goody Sun Drops Cancelled under Section 30(1)(c) of the Act

PREGNYL gonadotrophin - chorionic human 1500IU powder for injection vial with diluent vial Cancelled under Section 30(1)(c) of the Act

PREGNYL gonadotrophin - chorionic human 5000IU powder for injection vial with diluent vial Cancelled under Section 30(1)(c) of the Act

SINEMET CR levodopa/carbidopa 200 mg/50 mg modified release tablet bottle Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?